Perrigo Company plc - PRGO

PRGO Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
PRGO	-0.1	-4.5	-9.7	-4.6	-14.0	-27.2	-39.8	-59.6	-85.3	105.0
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare PRGO with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	PRGO
name	Perrigo Company plc
price	23.84
changes percentage	-0.08
change	-0.02
day low	23.63
day high	24.02
year high	33.96
year low	23.14
market cap	3252443520
price avg 50	26.53
price avg 200	27.55
exchange	NYSE
volume	715419
avg volume	1509006
open	23.83
previous close	23.86
eps	-1.07
pe	-22.28
earnings announcement	2025-03-03T12:00:00.000+0000
shares outstanding	136428000
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 56.3%

Overall Quarterly Financial Health: 77.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001585364
revenue	4655600000	4451600000	4.58
gross profit	1680400000	1455400000	15.46
gross profit ratio	0.36	0.33	10.40
research and development expenses	122500000	123100000	-0.49
operating expenses	1528500000	1334000000	14.58
interest income	0	140700000	-100.00
interest expense	173800000	156000000	11.41
ebitda	525000000	507200000	3.51
ebitdaratio	0.11	0.11	-1.84
operating income	151900000	172800000	-12.09
operating income ratio	0.03	0.04	-15.95
net income	-12700000	-130900000	90.30
net income ratio	-0.0	-0.03	90.72
eps	-0.09	-0.97	90.32

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 4,656 million in 2023 from 4,452 million in 2022 representing a change of 4.58%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,680 million in 2023 from 1,455 million in 2022 representing a change of 15.46%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 525 million in 2023 from 507 million in 2022 representing a change of 3.51%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Earnings per Share (EPS): EPS increased to -0.09 in 2023 from -0.09 in 2022 representing a change of 90.32%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 122 million in 2023 from 123 million in 2022 representing a change of -0.49%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 1,528 million in 2023 from 1,334 million in 2022 representing a change of 14.58%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 152 million in 2023 from 173 million in 2022 representing a change of -12.09%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -13 million in 2023 from -131 million in 2022 representing a change of 90.3%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001585364
revenue	1087500000	1065700000	2.05
gross profit	404400000	395000000	2.38
gross profit ratio	0.37	0.37	0.33
research and development expenses	26000000	29400000	-11.56
operating expenses	324000000	330200000	-1.88
interest income	0	0	NaN
interest expense	57600000	44100000	30.61
ebitda	79400000	67400000	17.80
ebitdaratio	0.07	0.14	-46.96
operating income	80400000	64800000	24.07
operating income ratio	0.07	0.06	21.59
net income	-21000000	-105700000	80.13
net income ratio	-0.02	-0.1	80.53
eps	-0.15	-0.77	80.52

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1,088 million in 2024Q3 from 1,066 million in 2024Q2 representing a change of 2.05%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 404 million in 2024Q3 from 395 million in 2024Q2 representing a change of 2.38%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 324 million in 2024Q3 from 330 million in 2024Q2 representing a change of -1.88%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 79 million in 2024Q3 from 67 million in 2024Q2 representing a change of 17.8%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 80 million in 2024Q3 from 65 million in 2024Q2 representing a change of 24.07%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to -21 million in 2024Q3 from -106 million in 2024Q2 representing a change of 80.13%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.15 in 2024Q3 from -0.15 in 2024Q2 representing a change of 80.52%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 26 million in 2024Q3 from 29 million in 2024Q2 representing a change of -11.56%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001585364
total assets	10809100000	11017300000	-1.89
total liabilities	6041200000	6175200000	-2.17
total equity	4767900000	4842100000	-1.53
cash and cash equivalents	751300000	600700000	25.07
short term investments	100000	100000	0.00
long term investments	91900000	209400000	-56.11
total current assets	2832900000	2719900000	4.15
total non current assets	7976200000	8297400000	-3.87
total current liabilities	1586300000	1113600000	42.45
total non current liabilities	4454900000	5061600000	-11.99
common stock	6837500000	6936700000	-1.43
retained earnings	-2080300000	-2067600000	-0.61
total debt	4073400000	4106600000	-0.81

Overall Score of Annual Balance Sheet

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 10,809 million in 2023 from 11,017 million in 2022 representing a change of -1.89%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 4,768 million in 2023 from 4,842 million in 2022 representing a change of -1.53%. This indicates a decrease in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities increased to 1,586 million in 2023 from 1,114 million in 2022 representing a change of 42.45%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 6,838 in 2023 from 6,937 in 2022 representing a change of -1.43%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to -2,080 million in 2023 from -2,068 million in 2022 representing a change of -0.61%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 6,041 million in 2023 from 6,175 million in 2022 representing a change of -2.17%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 751 million in 2023 from 601 million in 2022 representing a change of 25.07%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 2,833 million in 2023 from 2,720 million in 2022 representing a change of 4.15%. This indicates a better liquidity position.

  Total Debt: Total Debt decreased to 4,073 million in 2023 from 4,107 million in 2022 representing a change of -0.81%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001585364
total assets	11203200000	10397300000	7.75
total liabilities	6637200000	5852000000	13.42
total equity	4566000000	4545300000	0.46
cash and cash equivalents	1463500000	542800000	169.62
short term investments	0	0	NaN
long term investments	0	78300000	-100.00
total current assets	3707800000	2959100000	25.30
total non current assets	7495400000	7438199999	0.77
total current liabilities	1450500000	1488100000	-2.53
total non current liabilities	5186700000	4363900000	18.85
common stock	6763900000	6786200000	-0.33
retained earnings	-2207700000	-2186700000	-0.96
total debt	4753300000	4250899999	11.82

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 11,203 million in 2024Q3 from 10,397 million in 2024Q2 representing a change of 7.75%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 4,566 million in 2024Q3 from 4,545 million in 2024Q2 representing a change of 0.46%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,464 million in 2024Q3 from 543 million in 2024Q2 representing a change of 169.62%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 3,708 million in 2024Q3 from 2,959 million in 2024Q2 representing a change of 25.3%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 1,450 million in 2024Q3 from 1,488 million in 2024Q2 representing a change of -2.53%. This indicates a lower short-term debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 6,637 million in 2024Q3 from 5,852 million in 2024Q2 representing a change of 13.42%. This indicates an increase in overall liabilities.

  Common Stock: Common Stock decreased to 6,764 in 2024Q3 from 6,786 in 2024Q2 representing a change of -0.33%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to -2,208 million in 2024Q3 from -2,187 million in 2024Q2 representing a change of -0.96%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 4,753 million in 2024Q3 from 4,251 million in 2024Q2 representing a change of 11.82%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001585364
net change in cash	150600000	-1264200000	111.91
operating cash flow	405500000	307300000	31.96
free cash flow	303800000	210900000	44.05
capital expenditure	-101700000	-96400000	-5.50
depreciation and amortization	359500000	338600000	6.17
deferred income tax	-106600000	-50500000	-111.09
stock based compensation	68800000	54900000	25.32
accounts payables	-65900000	100300000	-165.70
inventory	19400000	-76700000	125.29
acquisitions net	0	-1952700000	100.00
investments in property plant and equipment	-101700000	-96400000	-5.50
net cash used for investing activites	-77500000	-1958600000	96.04
debt repayment	-30200000	616700000	-104.90
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-149700000	-142400000	-5.13
net cash used provided by financing activities	-187200000	421600000	-144.40
cash at end of period	751300000	600700000	25.07
accounts receivables	-57100000	100000	-57,200.00
cash at beginning of period	600700000	1864900000	-67.79

Overall Score of Annual Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 151 million in 2023 from -1,264 million in 2022 representing a change of 111.91%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 406 million in 2023 from 307 million in 2022 representing a change of 31.96%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 304 million in 2023 from 211 million in 2022 representing a change of 44.05%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -102 million in 2023 from -96 million in 2022 representing a change of -5.5%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 66 million in 2023 from 100 million in 2022 representing a change of -165.7%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -57 million in 2023 from 0 million in 2022 representing a change of -57200.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Stock-Based Compensation: Stock-Based Compensation increased to 69 million in 2023 from 55 million in 2022 representing a change of 25.32%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -150 million in 2023 from -142 million in 2022 representing a change of -5.13%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001585364
operating cash flow	42200000	9500000	344.21
free cash flow	15100000	-18900000	179.89
capital expenditure	-27100000	-28400000	4.58
depreciation and amortization	82300000	81900000	0.49
deferred income tax	-14800000	12300000	-220.33
stock based compensation	5900000	23000000	-74.35
accounts receivables	-52000000	34600000	-250.29
accounts payables	-18800000	30600000	-161.44
inventory	-11800000	-13500000	12.59
acquisitions net	205500000	-1600000	12,943.75
investments in property plant and equipment	-27100000	-28400000	4.58
net cash used for investing activites	212700000	-73300000	390.18
debt repayment	691900000	-9800000	7,160.20
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-37600000	-37700000	0.27
net cash used provided by financing activities	653300000	-49800000	1,411.85
net change in cash	920700000	-115700000	895.76
cash at end of period	1463500000	542800000	169.62
cash at beginning of period	542800000	658500000	-17.57

Overall Score of Quarterly Cashflow Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 921 million in 2024Q3 from -116 million in 2024Q2 representing a change of 895.76%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 42 million in 2024Q3 from 10 million in 2024Q2 representing a change of 344.21%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 15 million in 2024Q3 from -19 million in 2024Q2 representing a change of 179.89%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 6 million in 2024Q3 from 23 million in 2024Q2 representing a change of -74.35%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 19 million in 2024Q3 from 31 million in 2024Q2 representing a change of -161.44%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -52 million in 2024Q3 from 35 million in 2024Q2 representing a change of -250.29%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -38 million in 2024Q3 from -38 million in 2024Q2 representing a change of 0.27%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -27 million in 2024Q3 from -28 million in 2024Q2 representing a change of 4.58%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q3 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	34.41	33.1	3.96
net income per share	-0.09	-0.97	90.36
operating cash flow per share	3.0	2.28	31.18
free cash flow per share	2.25	1.57	43.20
cash per share	5.55	4.47	24.33
book value per share	35.24	36.0	-2.11
tangible book value per share	-12.91	-14.4	10.33
shareholders equity per share	35.24	36.0	-2.11
interest debt per share	31.39	31.69	-0.95
market cap	4353954000	4585105000	-5.04
enterprise value	7676054000	8091005000	-5.13
pe ratio	-342.83	-35.03	-878.75
price to sales ratio	0.94	1.03	-9.20
pocfratio	10.74	14.92	-28.04
pfcf ratio	14.33	21.74	-34.08
pb ratio	0.91	0.95	-3.56
ptb ratio	0.91	0.95	-3.56
ev to sales	1.65	1.82	-9.29
enterprise value over ebitda	14.62	15.95	-8.35
ev to operating cash flow	18.93	26.33	-28.10
ev to free cash flow	25.27	38.36	-34.14
earnings yield	-0.0	-0.03	89.78
free cash flow yield	0.07	0.05	51.70
debt to equity	0.85	0.85	0.74
debt to assets	0.38	0.37	1.10
net debt to ebitda	6.33	6.91	-8.46
current ratio	1.79	2.44	-26.88
interest coverage	0.87	1.11	-21.10
income quality	-31.93	-2.19	-1,360.86
dividend yield	0.03	0.03	10.71
payout ratio	-11.79	-1.09	-983.55
sales general and administrative to revenue	0.11	0.12	-2.52
research and ddevelopement to revenue	0.03	0.03	-4.85
intangibles to total assets	0.6	0.62	-2.04
capex to operating cash flow	0.25	0.31	-20.05
capex to revenue	0.02	0.02	0.88
capex to depreciation	0.28	0.28	-0.64
stock based compensation to revenue	0.01	0.01	19.83
graham number	8.63	28.08	-69.27
roic	0.01	0.02	-48.92
return on tangible assets	-0.0	-0.03	90.42
graham net net	-30.78	-33.28	7.51
working capital	1246600000	1606300000	-22.39
tangible asset value	-1747300000	-1937100000	9.80
net current asset value	-3208300000	-3455300000	7.15
invested capital	8861800000	9528900000	-7.00
average receivables	718350000	675000000	6.42
average payables	507500000	474250000	7.01
average inventory	1145600000	1085250000	5.56
days sales outstanding	57.98	57.16	1.45
days payables outstanding	58.6	65.45	-10.46
days of inventory on hand	139.97	140.13	-0.12
receivables turnover	6.29	6.39	-1.43
payables turnover	6.23	5.58	11.69
inventory turnover	2.61	2.6	0.12
roe	-0.0	-0.03	90.15
capex per share	0.75	0.72	4.87

• Negative

  ROE: Return on Equity (ROE) increased to -0.00 on 2023-12-31 from -0.03 on 2022-12-31, representing a change of 90.15%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -342.83 on 2023-12-31 from -35.03 on 2022-12-31, representing a change of -878.75%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.79 on 2023-12-31 from 2.44 on 2022-12-31, representing a change of -26.88%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.85 on 2023-12-31 from 0.85 on 2022-12-31, representing a change of 0.74%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-28 Q3	2024-06-29 Q2	Q/Q change %
PRGO
calendar year	2024	2024	NaN
revenue per share	7.91	7.77	1.75
net income per share	-0.15	-0.77	80.19
operating cash flow per share	0.31	0.07	342.92
free cash flow per share	0.11	-0.14	179.66
cash per share	10.64	3.96	168.84
book value per share	33.21	33.15	0.16
tangible book value per share	-11.03	-10.67	-3.33
shareholders equity per share	33.21	33.15	0.16
interest debt per share	34.99	31.33	11.69
market cap	3526875000	3520728000	0.17
enterprise value	6816675000	7228827999	-5.70
pe ratio	-41.99	-8.33	-404.21
price to sales ratio	3.24	3.3	-1.83
pocfratio	83.58	370.6	-77.45
pfcf ratio	233.57	-186.28	225.38
pb ratio	0.77	0.77	-0.28
ptb ratio	0.77	0.77	-0.28
ev to sales	6.27	6.78	-7.59
enterprise value over ebitda	85.85	107.25	-19.95
ev to operating cash flow	161.53	760.93	-78.77
ev to free cash flow	451.44	-382.48	218.03
earnings yield	-0.01	-0.03	80.17
free cash flow yield	0.0	-0.01	179.75
debt to equity	1.04	0.94	11.31
debt to assets	0.42	0.41	3.78
net debt to ebitda	41.43	55.02	-24.69
current ratio	2.56	1.99	28.55
interest coverage	1.4	1.47	-5.01
income quality	-2.02	-0.09	-2,146.56
dividend yield	0.01	0.01	-0.44
payout ratio	-1.79	-0.36	-402.00
sales general and administrative to revenue	0.11	0.12	-9.15
research and ddevelopement to revenue	0.02	0.03	-13.34
intangibles to total assets	0.54	0.58	-6.05
capex to operating cash flow	0.64	2.99	-78.52
capex to revenue	0.02	0.03	-6.49
capex to depreciation	0.33	0.35	-5.04
stock based compensation to revenue	0.01	0.02	-74.86
graham number	10.68	23.98	-55.46
roic	-0.01	0.01	-164.33
return on tangible assets	-0.0	-0.02	82.97
graham net net	-29.22	-30.54	4.34
working capital	2257300000	1471000000	53.45
tangible asset value	-1516200000	-1463100000	-3.63
net current asset value	-2929400000	-2892900000	-1.26
invested capital	9430800000	8592200000	9.76
average receivables	768750000	778650000	-1.27
average payables	465000000	462600000	0.52
average inventory	1125000000	1118750000	0.56
days sales outstanding	65.04	63.47	2.47
days payables outstanding	60.41	63.27	-4.52
days of inventory on hand	149.38	149.78	-0.27
receivables turnover	1.38	1.42	-2.41
payables turnover	1.49	1.42	4.74
inventory turnover	0.6	0.6	0.27
roe	-0.0	-0.02	80.22
capex per share	0.2	0.21	-4.86

• Negative

  ROE: Return on Equity (ROE) increased to -0.00 on 2024-09-28 Q3 from -0.02 on 2024-06-29 Q2, representing a change of 80.22%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -41.99 on 2024-09-28 Q3 from -8.33 on 2024-06-29 Q2, representing a change of -404.21%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 2.56 on 2024-09-28 Q3 from 1.99 on 2024-06-29 Q2, representing a change of 28.55%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None